ACADIA Pharmaceuticals Inc. $ ACAD % ; In the news. Simply Wall Street. 20 hours ago. Shareholders in Adaptive Biotechnologies (NASDAQ:ADPT) have lost. Adaptive Biotechnologies/ADPT · $ · About Adaptive Biotechnologies · ADPT Metrics · What the Analysts think about ADPT · ADPT Financial Performance · ADPT. Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular. Adaptive Biotechnologies Corp (ADPT) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Get the latest Adaptive Biotechnologies Corporation (ADPT) stock news and headlines to help you in your trading and investing decisions.
Adaptive Biotechnologies Corporation NASDAQ: ADPT is a company focused on using the biology of the adaptive immune system to develop the diagnosis and. Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical. 16 minutes ago. As of last trade Adaptive Biotechnologies Corp (ADPT:NSQ) traded at , % below its week high of , set on Sep 01, week range. Today. PROFILE (ADPT). Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ. Adaptive Biotechnologies Corp. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - NASDAQ GS: ADPT. $ Sep 6, PM EDT. Change. (%). Volume. , Today's Open. $ Previous Close. $ Market Cap. Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on harnessing the inherent biology of the adaptive. Get the latest updates on Adaptive Biotechnologies Corporation Common Stock (ADPT) pre market trades, share volumes, and more. What Is the Adaptive Biotechnologies Corp Stock Price Today? The Adaptive Biotechnologies Corp stock price today is What Is the Stock Symbol for Adaptive. On average, Wall Street analysts predict that Adaptive Biotechnologies's share price could reach $ by Aug 2, The average Adaptive Biotechnologies.
Adaptive Biotechnologies Corporation ; Open. ; High. ; 52wk High. ; Volume. m ; Beta. Adaptive Biotechnologies stock down % in premarket trade Shares of Adaptive Biotechnologies Corp. fell % in premarket trade Wednesday after the company. Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular. A high-level overview of Adaptive Biotechnologies Corporation (ADPT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. Discover real-time Adaptive Biotechnologies Corporation Common Stock (ADPT) stock prices, quotes, historical data, news, and Insights for informed trading. Stock analysis for Adaptive Biotechnologies Corp (ADPT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Adaptive Biotechnologies Corp ADPT:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/13/23 · 52 Week Low · The current price of ADPT is USD — it has decreased by −% in the past 24 hours. Watch Adaptive Biotechnologies Corporation stock price performance more. Adaptive Biotechnologies is harnessing the immune system to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in.
Find the latest Adaptive Biotechnologies Corporation (ADPT) stock quote, history, news and other vital information to help you with your stock trading and. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. Adaptive Biotechnologies is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Adaptive Biotechnologies's. Track Adaptive Biotechnologies Corp (ADPT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Adaptive Biotechnologies Corp ; Jun, Initiated, Goldman, Buy, $60 ; Jul, Initiated, BTIG Research, Buy, $
Adaptive Biotechnologies' Immune Medicine Platform / We've Arrived
Adaptive Biotechnologies Corp (ADPT) ; Buy. 78%Buy. 21%Hold. 0. 0%Sell ; Hold. 0 ; Current $ ; Target $ ; Technicals Summary. Sell. Neutral. Buy. Adaptive. You can buy Adaptive Biotechnologies Corp (ADPT) stock and many other stocks or ETFs on Stash. Purchase fractional shares with any dollar amount. Adaptive Biotechnologies (ADPT) - Develops an immune medicine platform for the diagnosis and treatment of various diseases. · Is Amgen Stock A Buy As The Biotech. On what stock exchange are Adaptive Biotechnologies shares traded and what is the ticker symbol? Our ticker is ADPT and our shares are traded on the Nasdaq. Explore the latest news, in-depth analysis, performance evaluation, and Q&A for Adaptive Biotechnologies Corp. (ADPT) stock. Gain valuable insights from.
Adaptive Biotechnologies ADPT Q1 2024 Earnings Presentation